Brief pearls for diagnosis and management of ascites and relevant conditions associated with decompensated cirrhosis.Read More
Celiac disease is more than twice as common in people with cirrhosis of the liver than in the general population, a new study says — indicating that routine screening for Celiac disease may be warranted for these patients.
Meet Dr. Michael J. Rosen, the new Director of Cleveland Clinic’s Hernia Center, one of only a handful of such centers across the country. Find out why he’s passionate about hernia surgery and how he’s innovating every day.
Cleveland Clinic research results may help combat the organ donor shortage. Partial liver transplants have comparable survival rates to those of whole organ procedures after five years
A sea change may be ahead for minimally invasive surgical treatment of colorectal disease. Robotic surgery to treat rectal cancer offers better visualization, dexterity and retraction than traditional laparoscopy.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Physicians in the Digestive Disease Institute’s Endoscopy Section are optimizing patient care through use of several new technologies.
First, they are evaluating Hemospray powder (Cook Medical, Winston-Salem, N.C.) to control diffuse gastrointestinal bleeding.
The Intensive Review of Gastroenterology & Hepatology (a boot camp for GI boards), happening August 23-26, 2014 at Loews Coronado Bay in San Diego, CA, is a course that provides an intensive review of gastroenterology and hepatology through the lens of successful test-taking. It is targeted for candidates preparing for both initial certification and maintenance of re-certification AND for those in clinical practice who need a high-paced intensive review of the field. To meet the high standards required to pass the boards, we have put together this intensive review course which brings outstanding teachers from Cleveland Clinic and other leading institutions.
Before this 4-year-old boy got a four-organ transplant (intestine, duodenum, liver and pancreas), no one with Martinez-Frias syndrome survived past toddlerhood. Now 5, the boy is cured of his diabetes, off TPN and thriving. Lead transplant surgeon, Kareem Abu-Elmagd, MD, is gratified.
Exhaled breath analysis shows promise for noninvasive diagnosis
Jeffrey Ponsky, MD, has rejoined Cleveland Clinic in a newly created role focused on his passion for hands-on clinical innovations. Hear his thoughts on what’s next in minimally invasive surgery.
FMT is a ground-breaking treatment for diarrhea caused by Clostridium difficile bacteria. By transferring “healthy” bacteria from a donor into a patient’s intestines, it’s hoped the proper balance of bacteria will be restored.